This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical relevance, comparing emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke and neurodegenerative disorders.
Biomarkers of Cardiometabolic Risk, Inflammation and Disease is aimed at doctors specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or endocrinology and will also be of interest to GPs, trainee doctors and clinical and basic researchers working on cardiovascular and autoimmune disorders.
Inflammation biomarkers and cardiometabolic risk.- Cardiovascular disease.- Diabetes mellitus and metabolic syndrome.- Ischemic stroke.- Chronic kidney disease.- Immune-mediated inflammatory rheumatic diseases.- Cardiometabolic risk, inflammation and neurodegenerative disorders.
Filipe Palavra, MD
Laboratory of Pharmacology and Experimental Therapeutics
Institute for Biomedical Imaging and Life Sciences (IBILI)
Faculty of Medicine, Coimbra University
Coimbra, Portugal
Flávio Reis, PhD
Laboratory of Pharmacology and Experimental Therapeutics
Institute for Biomedical Imaging and Life Sciences (IBILI)
Faculty of Medicine, Coimbra University
Coimbra, Portugal
Daniela Marado, MD
Department of Internal Medicine - B
Centro Hospitalar e Universitário de Coimbra
Coimbra, Portugal
Armando Sena, MD, PhD
Interdisciplinary Centre of Research Egas Moniz, CiiEM
Caparica, Portugal
